Basler is showing signs of recovery, with a reported return to profitable growth, sending its shares up over 5% on Friday.
The company confirmed its previously reported FY24 preliminary results and released guidance that exceeded expectations.
Sales expectations for FY25 are between €186 million and €198 million, representing a year-over-year increase of 1% to 8%, which is ahead of the consensus expectation of a slight decline of 1%.
The EBT margin is guided to be 0-5%, implying €4.8 million at the midpoint. There’s also positive momentum in orders, indicated by an improved order momentum in 4Q24, with the book-to-bill ratio at 1.3x, compared to 0.9x in 3Q24.
Basler implemented cost-saving measures announced in October at the end of last year, which has resulted in lowering the group’s break-even point to approximately €180 million of sales.
To manage finances, management previously proposed suspending dividends for FY24 to conserve liquidity and restore resilience.
Looking further ahead, management aims to achieve group sales of more than €275 million by 2028, targeting a group EBT margin of 12%.
Key results from 4Q24 include revenue of €47 million, a 3% year-over-year increase and a 7% quarter-over-quarter increase, which was above expectations.
New orders reached €58.9 million, a 53% year-over-year increase and a 44% quarter-over-quarter increase.
For the full year 2024, revenue was €183.7 million, which also exceeded expectations. New orders totaled €192.4 million.
